Hetero Labs Ltd V Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HETERO LABS LTD V, and what generic and branded alternatives to HETERO LABS LTD V drugs are available?
HETERO LABS LTD V has fifty-seven approved drugs.
There are three tentative approvals on HETERO LABS LTD V drugs.
Summary for Hetero Labs Ltd V
| US Patents: | 0 |
| Tradenames: | 53 |
| Ingredients: | 52 |
| NDAs: | 57 |
Drugs and US Patents for Hetero Labs Ltd V
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hetero Labs Ltd V | TELMISARTAN | telmisartan | TABLET;ORAL | 205901-001 | Apr 22, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hetero Labs Ltd V | LACOSAMIDE | lacosamide | TABLET;ORAL | 204787-002 | Mar 17, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hetero Labs Ltd V | ALLOPURINOL | allopurinol | TABLET;ORAL | 217748-001 | Aug 3, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hetero Labs Ltd V | TELMISARTAN | telmisartan | TABLET;ORAL | 205901-002 | Apr 22, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hetero Labs Ltd V | FESOTERODINE FUMARATE | fesoterodine fumarate | TABLET, EXTENDED RELEASE;ORAL | 204792-002 | Jan 9, 2024 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
